Back to Feed
总结
多家媒体报道，研究人员提出一种利用癌细胞在治疗过程中形成的耐药突变来反制肿瘤的新策略。该方法把原本导致药物失效的突变蛋白视为可识别的“靶点”或“弱点”，据此设计新的药物或免疫疗法，使免疫系统或新分子更精准攻击携带突变的癌细胞，从而在肿瘤对既有疗法不再响应时提供替代方案。相关成果有望拓展耐药癌症的治疗选择，并推动个体化用药与免疫治疗研发。
正文
Researchers use cancer's drug-resistance mutations to fight tumors news.cgtn.com Researchers Discover A New Method To Fight Cancers That No Longer Respond To Treatment NDTV Turning mutant proteins into drugs that attack cancer cells' weak spots Earth.com Researchers turn cancer resistance mutations into targets for new immunotherapies Medical Xpress Researchers harness cancer resistance mutations to fight tumours DD News
发布时间：